Form 4: Orthopediatrics Corp Director Terry D. Schlotterback Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Terry D. Schlotterback reported acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.
Summary
- On May 28, 2024, Terry D. Schlotterback, a director of Orthopediatrics Corp, acquired 2,766 shares of common stock.
- The acquisition was a direct transaction.
- Following the transaction, Schlotterback directly owns 18,218 shares of common stock, which includes 4,640 restricted stock awards.
- Additionally, Schlotterback indirectly owns 2,546 shares through their spouse.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director. While insider buying can be seen as a positive signal, it's not a strong indicator on its own.
Positives
- The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Date of transaction: Acquisition of common stock. |
| 05/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.